PBS Ozempic savings calculator how much you save vs private (Australia 2026)

The Health Desk · Editorial team, aged care + dental + plastic surgery + dermatology + weight-loss + psychology · Updated 14 May 2026 · How we rank · Editorial standards

If you qualify for PBS Authority Streamlined Ozempic (type 2 diabetes patients meeting criteria), the saving vs private cost is dramatic. This calculator gives you the real numbers over 1 to 10 years. Use it to pressure-test whether the PBS pathway is worth pursuing.

★Key takeaways

  • ✓PBS Ozempic for T2D: $31.60/month general or $7.70/month concession.
  • ✓Private Ozempic: the private retail price (varies by pharmacy) retail or $290-$450/month telehealth.
  • ✓Annual saving for general PBS vs private retail: around $4,500.
  • ✓Annual saving for concession PBS vs private retail: around $4,800.
  • ✓Over 5 years, PBS access saves a typical T2D patient $22,000-$24,000.

Run the calculation

All inputs save to the URL so you can share your result.

Concession = Pension, Health Care, or Commonwealth Seniors Health card.

Your estimated savings

$0

over 0 years on treatment

PBS pathway

$0

$0/month

Private pathway

$0

$0/month

Excludes GP consultation costs. PBS pathway requires you meet Authority Streamlined criteria (confirmed T2D, HbA1c above threshold, on existing therapy). Check your eligibility with our PBS Authority decision tree.

Why the saving is so large

The Australian Federal Government heavily subsidises PBS medications. For chronic disease management drugs like Ozempic for type 2 diabetes, the difference between PBS-subsidised and private pricing is around 14x for general patients and around 50x for concession card holders.

This is by design. PBS exists to keep chronic disease medication affordable for the population that needs it most. The catch is the strict eligibility criteria, Authority Streamlined for semaglutide requires a confirmed type 2 diabetes diagnosis with HbA1c above threshold on existing therapy. Weight loss, pre-diabetes, PCOS and other indications do not qualify.

If you do not qualify for PBS

Most Australian patients using GLP-1 medications for weight loss do not qualify for PBS subsidy. The realistic comparison is between private retail pharmacy + GP visits versus telehealth bundle. Telehealth typically wins on cost by $50-$200/month for the same TGA-registered medication.

Use our GLP-1 switch cost calculator to compare full out-of-pocket cost across Ozempic, Wegovy, Mounjaro, and Saxenda over 12 and 24 months, including GP visits and dose escalation.

What you should do with this number

  • If the saving is large enough to matter: book a GP appointment to assess your PBS eligibility. The criteria are specific but not exotic. A long consultation, HbA1c blood test, and Authority Streamlined script can save you $5,000+/year.
  • If you are not PBS-eligible: the conversation shifts to which private pathway minimises cost. Telehealth bundles usually win. 10 ways to save money on Ozempic.
  • If the saving is significant: consider whether you should defer or change non-PBS-eligible weight loss plans. Sometimes treating the underlying T2D first (with PBS-subsidised Ozempic) drives weight loss as a side benefit.

Related coverage

Common questions

PBS savings: frequently asked questions

How accurate are these calculations?

Calculations use 2026 PBS pricing ($31.60 general, $7.70 concession), standard private retail Ozempic pricing (the private retail price (varies by pharmacy)), and telehealth bundle pricing ($290-$450/month). Real prices vary by pharmacy, telehealth provider, and dose level. The calculator gives a realistic order-of-magnitude figure, not a guaranteed quote.

Does this include GP visit costs?

No, just medication. GP consultation costs vary widely: bulk-billed (free to patient), private mixed-billing ($40-$120 out-of-pocket after Medicare rebate), or specialist consult ($150-$300 out-of-pocket). Add those to the private pathway estimates for the full picture.

Why is concession pricing so much cheaper?

PBS concession applies to holders of a Pension Concession Card, Health Care Card, Commonwealth Seniors Health Card, or DVA cards. Concession patients pay $7.70/script (general patients pay $31.60). For ongoing chronic medication, that is a meaningful annual saving (around $290/year just on Ozempic).

What happens if I lose PBS eligibility?

If your HbA1c improves below threshold or you switch to a non-T2D treatment goal, your prescriber may stop renewing the Authority Streamlined code and you would pay private price ($380+/month) for ongoing supply.

Does this work for Wegovy or Mounjaro savings?

No. Wegovy and Mounjaro are not PBS-subsidised in 2026, so there is no PBS savings comparison available. The same private pricing applies regardless of indication. Use our GLP-1 switch cost calculator to compare full out-of-pocket costs across drugs.